Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing Pu

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Metabolomic, Lipidomic, and Enterohormone Changes in the Progression from MASLD to MASHJaclyn A Rivas, Alexandria C Murphy, Praveena Prasad, et al.
Metabolism: Clinical and Experimental|May 21, 2026
Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitisJaclyn A Rivas, Alexandria C Murphy, Praveena Prasad, et al.
The New England Journal of Medicine|February 28, 2014
An inactivated enterovirus 71 vaccine in healthy childrenRongcheng Li, Longding Liu, Zhaojun Mo, et al.
Vaccine|May 25, 2024
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicityJin-Yuan Wu, Wei Zhang, Jing Pu, et al.
BMC Medicine|September 19, 2015
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observationsLongding Liu, Zhaojun Mo, Zhenglun Liang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2020
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy AdultsYanchun Che, Xiaoqiang Liu, Yi Pu, et al.
NPJ Vaccines|February 29, 2024
Immune persistence after different polio sequential immunization schedules in Chinese infantsTing Zhao, Jing Li, Teng Huang, et al.
Vaccine|April 20, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trialJing Pu, Qin Yu, Zhifang Yin, et al.
NPJ Vaccines|April 23, 2025
Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccinesYuting Fu, Rufei Ma, Zhimei Zhao, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Vaccines|May 7, 2025
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialYan Liu, Guangwei Feng, Jinyuan Wu, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Metabolomic, Lipidomic, and Enterohormone Changes in the Progression from MASLD to MASHJaclyn A Rivas, Alexandria C Murphy, Praveena Prasad, et al.
Metabolism: Clinical and Experimental|May 21, 2026
Gut-liver metabolic and enterohormonal remodeling drives progression from metabolic dysfunction-associated steatotic liver disease to steatohepatitisJaclyn A Rivas, Alexandria C Murphy, Praveena Prasad, et al.
The New England Journal of Medicine|February 28, 2014
An inactivated enterovirus 71 vaccine in healthy childrenRongcheng Li, Longding Liu, Zhaojun Mo, et al.
Vaccine|May 25, 2024
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicityJin-Yuan Wu, Wei Zhang, Jing Pu, et al.
BMC Medicine|September 19, 2015
Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observationsLongding Liu, Zhaojun Mo, Zhenglun Liang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2020
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy AdultsYanchun Che, Xiaoqiang Liu, Yi Pu, et al.
NPJ Vaccines|February 29, 2024
Immune persistence after different polio sequential immunization schedules in Chinese infantsTing Zhao, Jing Li, Teng Huang, et al.
Vaccine|April 20, 2021
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trialJing Pu, Qin Yu, Zhifang Yin, et al.
NPJ Vaccines|April 23, 2025
Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccinesYuting Fu, Rufei Ma, Zhimei Zhao, et al.
Pageof 22